Kestra Medical Technologies, Ltd. Common Stock (KMTS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a cash flow conversion efficiency ratio of -0.064x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-18.37 Million) by net assets ($287.99 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Kestra Medical Technologies, Ltd. Common defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Kestra Medical Technologies, Ltd. Common Stock - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Kestra Medical Technologies, Ltd. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kestra Medical Technologies, Ltd. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kestra Medical Technologies, Ltd. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tarkett SA
PA:TKTT
|
-0.097x |
|
Bafang Electric Suzhou Co Ltd
SHG:603489
|
0.017x |
|
Systex Corp
TW:6214
|
0.254x |
|
Guangzhou Restaurants Group Co
SHG:603043
|
0.243x |
|
Truworths International Ltd
JSE:TRU
|
0.251x |
|
Episil-Precision Inc
TW:3016
|
0.019x |
|
Shenzhen Cotran New Material Co Ltd Class A
SHE:300731
|
0.025x |
|
SMA SOLAR T. UNSP.ADR/01
F:S93
|
-0.017x |
Annual Cash Flow Conversion Efficiency for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
The table below shows the annual cash flow conversion efficiency of Kestra Medical Technologies, Ltd. Common Stock from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Kestra Medical Technologies, Ltd. Common.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $205.41 Million | $-77.61 Million | -0.378x | -209.52% |
| 2024-04-30 | $-209.38 Million | $-72.23 Million | 0.345x | -41.75% |
| 2023-04-30 | $-117.58 Million | $-69.64 Million | 0.592x | +103.50% |
| 2021-04-30 | $1.77 Million | $-29.89 Million | -16.928x | -115.53% |
| 2020-04-30 | $3.86 Million | $-30.29 Million | -7.854x | -- |
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, thera… Read more